Localised Leishmaniasis of Oral Mucosa: Report of an Unusual Clinicopathological Entity by Deepak Passi, Sarang Sharma, Shubharanjan Dutta, Chandan Gupta

“…There are three main clinical forms of leishmaniasis: visceral leishmaniasis, cutaneous leishmaniasis, and mucocutaneous leishmaniasis. …”
Get full text

INTEGUMENTARY AND VISCERAL EPIDEMIOLOGICAL PROFILE OF LEISHMANIASIS IN MONTES CLAROS COUNTY by Fabricio Xavier Oliveira Pinheiro, Victoria Liery Ribeiro Alves, Yure Batista de Sousa, Mirela Lopes Figueiredo, Ana Augusta Maciel de Souza, Patrícia Fernandes Prado

“… The present study aims to describe the epidemiological profile American Integumentary Leishmaniasis (LTA)and Visceral Leishmaniasis (LV) in the Montes Claros/MG population between 2016 to 2020. …”
Get full text

Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis by Adriana Bezerra-Souza, Jéssica A. Jesus, Márcia D. Laurenti, Aikaterini Lalatsa, Dolores R. Serrano, Luiz Felipe D. Passero

“…This drug was active on parasites that cause cutaneous and visceral leishmaniasis. Based on the leishmanicidal activity of butenafine chloride and considering the absence of reports about the therapeutic potential of this drug in cutaneous leishmaniasis, the present work is aimed at analyzing the efficacy of butenafine formulated in two different topical delivery systems, the self-nanoemulsifying drug delivery systems (BUT-SNEDDS) and in a SNEDDS-based nanogel (BUT-SNEDDS gel) as well as in the free form in experimental cutaneous leishmaniasis. …”
Get full text

Epidemiological analysis of Leishmaniasis prevalence in Pakistan during 2016-2023 by R. Uppal, U. Saeed, M. E. Khattak, A. A. Khan, M. R. Uppal, Z. Z. Piracha, M. N. Khan, D. Shaikh, U. Tariq, A. R. Mahmood, S. S. Ali, B. Muhammad, M. N. Tariq, S. S. Gilani, D. U. Ozsahin, B. Uzun, I. Ozsahin

Subjects: “…leishmaniasis…”
Get full text

Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review by Pashupati Pokharel, Rakesh Ghimire, Pratik Lamichhane

“…Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishmaniasis. Despite limited therapies for visceral leishmaniasis and emerging drug resistance, a proper review on the action of paromomycin for kala-azar is lacking. …”
Get full text

Molecular diagnosis and epidemiological aspects of cutaneous Leishmaniasis in Aleppo: Current status by Lana Kourieh, Mohammad Y. Abajy, Mahasen Alkebajy, Silva Ishkhanian, Ream Nayal

Subjects: “…Cutaneous leishmaniasis…”
Get full text

Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments by José A. O'Daly, Humberto M. Spinetti, Joe Gleason, María B. Rodríguez

“…Patients (n=87) from a cutaneous leishmaniasis (CL) hyperendemic region receiving different treatments were followed up from January 1994 to August 2000. …”
Get full text

Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model by Atteneri López-Arencibia, Carlos J. Bethencourt-Estrella, Desirée San Nicolás-Hernández, Rubén L. Rodríguez-Expósito, Angélica Domínguez-de-Barros, Lizbeth Salazar-Villatoro, Maritza Omaña-Molina, Francisco Cen-Pacheco, Ana R. Díaz-Marrero, José J. Fernández, Elizabeth Córdoba-Lanús, Jacob Lorenzo-Morales, José E. Piñero

Subjects: Get full text

A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules by Tejaswini Masne, Dileep Kumar, Deepali Bansode

Subjects: Get full text

Challenges in the Therapy of Visceral Leishmaniasis in Brazil: A Public Health Perspective by Edson Carvalho de Melo, Carlos Magno Castelo Branco Fortaleza

Get full text

Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh by Megha Raj Banjara, Siddhivinayak Hirve, Niyamat Ali Siddiqui, Narendra Kumar, Sangeeta Kansal, M. Mamun Huda, Pradeep Das, Suman Rijal, Chitra Kumar Gurung, Paritosh Malaviya, Byron Arana, Axel Kroeger, Dinesh Mondal

Get full text

Microspatial Distributional Patterns of Vectors of Cutaneous Leishmaniasis in Pernambuco, Northeastern Brazil by Maria Rita Donalisio, A. Townsend Peterson, Pietra Lemos Costa, Fernando José da Silva, Hélio França Valença, Jeffrey J. Shaw, Sinval P. Brandão Filho

“…The purpose of this study is to analyze the spatial distribution and population trends through time of Lutzomyia species in a long-term focus of cutaneous leishmaniasis transmission in an Atlantic Forest area, northeastern Brazil. …”
Get full text

Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL) by Emily R. Adams, Inge Versteeg, Mariska M. G. Leeflang

“…Identification of post-kala-azar dermal leishmaniasis (PKDL) is important due to the long and toxic treatment and the fact that PKDL patients may serve as a reservoir for visceral leishmaniasis (VL). …”
Get full text

Lingual Leishmaniasis Presenting to Maxillofacial Surgery in UK with Successful Treatment with Miltefosine by K. Kassam, R. Davidson, P. J. Tadrous, M. Kumar

“…Leishmaniasis is a disease that is caused by protozoa of the genus Leishmania, which is prevalent in tropical and subtropical areas. …”
Get full text

Temporal Validation of a Predictive Score for Death in Children with Visceral Leishmaniasis by Juliana Foinquinos, Maria do Carmo Duarte, Jose Natal Figueiroa, Jailson B. Correia, Nara Vasconcelos Cavalcanti

“…To perform a temporal validation of a predictive model for death in children with visceral leishmaniasis (VL). Methods. A temporal validation of a children-exclusive predictive model of death due to VL (Sampaio et al. 2010 model), using a retrospective cohort, hereby called validation cohort. …”
Get full text

The EP3622 clone of CD1a for diagnosing intestinal leishmaniasis in an acquired immunodeficiency syndrome patient in Colombia by Diego Andrés Rodríguez-Lugo, Jorge Alfredo Morcillo Muñoz, Javier Hernández Moreno, Carolina Moreno Reyes, Luz Helena Patiño, David F. Martínez, Juan Fernando Contreras-Valero, Juan David Ramírez, Álvaro A. Faccini-Martínez

Subjects: “…Leishmaniasis…”
Get full text

Insights into the transmission cycle of cutaneous leishmaniasis from an endemic community in rural Guatemala by Yaimie Lopez, Aitor Casas-Sanchez, Byron Arana, Nidia Rizzo, Erick Duran, Norma Padilla, Andrea de la Vega, Esteban Bustamante, Álvaro Acosta-Serrano, Renata Mendizabal-Cabrera

Subjects: Get full text

Some Epidemiological Aspects of Cutaneous Leishmaniasis in a New Focus, Central Iran by M. R. Yaghoobi-Ershadi, N. Marvi-Moghadam, R. Jafari, A. A. Akhavan, H. Solimani, A. R. Zahrai-Ramazani, M. H. Arandian, A. R. Dehghan-Dehnavi

“…Following the epidemic of cutaneous leishmaniasis in Khatam County, Yazd Province, this study was carried out to determine vector, and animal reservoir host(s) and investigate the human infection during 2005-2006. …”
Get full text

Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis by Mohamad Javad Yazdanpanah, Mahnaz Banihashemi, Fakhrozaman Pezeshkpoor, Mohammad Khajedaluee, Sororozaman Famili, Iman Tavakoli Rodi, Hadis Yousefzadeh

“…The purpose of this study was to investigate comparison between oral zinc sulfate and meglumine antimoniate in the treatment of cutaneous leishmaniasis (CL). So 100 patients with CL were included and randomly divided into two groups. …”
Get full text

Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis by Jéssica Adriana de Jesus, Márcia Dalastra Laurenti, Leila Antonangelo, Caroline Silvério Faria, João Henrique Ghilardi Lago, Luiz Felipe Domingues Passero

“…Leishmaniasis is a neglected tropical disease caused by the flagellated protozoa of the genus Leishmania that affects millions of people around the world. …”
Get full text